The Role of mTOR Inhibitors after Liver Transplantation for Hepatocellular Carcinoma

Liver transplantation is a treatment option for nonresectable patients with early-stage HCC, with more significant advantages when Milan criteria are fulfilled. An immunosuppressive regimen is required to reduce the risk of graft rejection after transplantation, and CNIs represent the drugs of choic...

Descripción completa

Detalles Bibliográficos
Autores principales: Todeschini, Letizia, Cristin, Luca, Martinino, Alessandro, Mattia, Amelia, Agnes, Salvatore, Giovinazzo, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297627/
https://www.ncbi.nlm.nih.gov/pubmed/37366904
http://dx.doi.org/10.3390/curroncol30060421

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297627/
https://www.ncbi.nlm.nih.gov/pubmed/37366904
http://dx.doi.org/10.3390/curroncol30060421

Ejemplares similares